HomeInsightsPE

Shukra Pharmaceuticals Ltd PE Ratio

Shukra Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

4.6 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

PE

17.9

Last updated on: Nov 25, 2024

Key Highlights

  • The P/E Ratio of Shukra Pharmaceuticals Ltd is 17.9 as of 25 Nov 11:20 AM .
  • The P/E Ratio of Shukra Pharmaceuticals Ltd changed from 12.4 on March 2019 to 19.3 on March 2024 . This represents a CAGR of 7.65% over 6 years.
  • The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 58.89 as of 25 Nov 11:08 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Shukra Pharmaceuticals Ltd

No data available

Company Fundamentals for Shukra Pharmaceuticals Ltd

No data available

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

Share Price

₹ 58.89

-0.01 (-0.02%)

stock direction

Last updated on: Nov 25, 2024

Market Price of Shukra Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202458.9
21 Nov 202458.28
19 Nov 202460.39
18 Nov 202462.68
14 Nov 202465.97
13 Nov 202464.93
12 Nov 202466.36
11 Nov 202469.15
08 Nov 202466.08
07 Nov 202467.87

SWOT Analysis Of Shukra Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Shukra Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Shukra Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Shukra Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Shukra Pharmaceuticals Ltd

No data available

* All values are in %

About Shukra Pharmaceuticals Ltd

  • Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September, 2016.
  • The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele.
  • Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

Shukra Pharmaceuticals Ltd News Hub

News

Shukra Pharmaceuticals standalone net profit rises 16.67% in the June 2024 quarter

Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended Jun...

Read more

2024-08-13 00:00:00

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

2024-08-05 00:00:00

News

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company...

Read more

2024-09-16 00:00:00

News

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 ...

Read more

2024-09-24 00:00:00

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

2024-11-08 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Shukra Pharmaceuticals Ltd

What is the current PE Ratio of Shukra Pharmaceuticals Ltd?

The Current PE Ratio of Shukra Pharmaceuticals Ltd is 17.85 as on 25 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 25 Nov 2024.

What was the PE Ratio of Shukra Pharmaceuticals Ltd last year?

The PE Ratio of Shukra Pharmaceuticals Ltd was 4.17 last year, now the PE ratio is 17.85, showing a year-on-year growth of 328.1%.

What does the PE Ratio of Shukra Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Shukra Pharmaceuticals Ltd is 17.85. This ratio indicates that investors are willing to pay 17.85 times the earnings per share for each share of Shukra Pharmaceuticals Ltd.

What is the PE Ratio Growth of Shukra Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Shukra Pharmaceuticals Ltd grew by 328.1% whereas, the EPS ratio grew by 127.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*